Home » Health » Hexavalent Vaccine Added to Colombia’s Immunization Program

Hexavalent Vaccine Added to Colombia’s Immunization Program

by Dr. Michael Lee – Health Editor

Colombia Expands Childhood Immunization with Hexavalent ‍Vaccine

BOGOTÁ – ColombiaS Ministry of Health has added the hexavalent acellular vaccine to the Expanded Immunization ⁢Program (PAI), a move aimed at bolstering protection for babies born⁣ with low weight-a population especially ‌vulnerable to serious health complications. The vaccine, which​ combines protection against⁢ diphtheria,⁣ tetanus, pertussis (whooping cough), Hepatitis B, poliomyelitis, and Haemophilus influenzae ‍type B, will be prioritized ⁢for at-risk infants.

The implementation​ of the hexavalent vaccine represents a‍ modernization​ of Colombia’s national ‌vaccination scheme, mandated by Law ⁤2406 of 2024‍ and supported by viability⁢ studies outlined​ in Law 2329 of 2023. It does​ not replace the pentavalent vaccine,‍ but offers a‍ more efficient and less⁢ painful alternative for children requiring specialized care.

The ‍vaccination schedule consists ⁤of three doses administered ​at 2, 4, and 6 months, with the option to begin as early as⁤ six weeks due to current whooping cough circulation.‌ Eligible beneficiaries include children born on or after April ⁣1, 2025, weighing less than 1,500 grams who have not received any​ pentavalent doses, those who started a pentavalent scheme but⁢ did⁤ not complete it, or those who experienced adverse ⁤effects following pentavalent ​vaccination. Infants born between january and March 2025 without a vaccination history will also‍ be included.

According to Health Minister⁣ Guillermo Alfonso Jaramillo, the hexavalent vaccine offers benefits such⁣ as reduced multiple punctures, increased adherence to the vaccination schedule, and a lower ‌incidence of adverse ‍events like fever, febrile seizures,​ apnea, or hypotonia.

Colombia currently⁤ offers ‌23‍ vaccines ⁢protecting against over 30 diseases, maintaining ⁢one ⁤of the most comprehensive immunization schemes in⁢ Latin America. Accomplished implementation of the hexavalent⁢ vaccine will ‌rely on collaboration‌ between Entidades Promotoras de Salud (EPS), Instituciones ⁢Prestadoras de Servicios de Salud (IPS), kangaroo programs, and⁢ early childhood care facilities to identify,⁢ monitor, ‌and vaccinate low-weight⁢ infants.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.